A review of the safety and tolerability of aripiprazole.
about
Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in KoreaAripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.Switching to aripiprazole as a strategy for weight reduction: a meta-analysis in patients suffering from schizophreniaRelapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial.Update on the role of antipsychotics in the treatment of Tourette syndrome.Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disordersTreatment strategies for tics in Tourette syndrome.Tolerability profile of aripiprazole in patients with Tourette syndrome.Aripiprazole treatment for patients with schizophrenia: from acute treatment to maintenance treatment.Treatment-emergent adverse events associated with atypical antipsychotics.Management of chronic depressive patients with residual symptoms.Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection.Cardiovascular safety of antipsychotics: a clinical overview.Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole.Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months.Sertindole: dilemmas for its use in clinical practice.
P2860
Q33662847-3529F05D-69CE-44D3-8363-615698CA2775Q33799660-8ADAAAFF-E310-42D9-8916-4BFC9B9E7E18Q34143822-E24C1DD6-937A-4451-8954-E6C5EB029320Q34660553-C8E53982-1430-41E2-AE07-908BB9A4146DQ35839717-39F174FA-D694-4D0F-B4DE-FF400BC1C90DQ36873932-3B9EB057-5B82-44EA-A5E7-451BDFF57A8BQ37845661-06ED6916-98E8-4612-9355-4DE818417891Q37913715-09CE7C80-CEA3-42D9-9E8C-C3DB8CCE0475Q37947687-C5D266A7-7022-4512-B913-F7E1354AEA48Q37981271-21358F4B-FF72-44FC-8D4A-090C19228059Q38109593-57C8A89D-DBF1-495C-8154-51A3064F5869Q38248274-F028E01C-C22D-4DD5-AB61-D5E760FFEF4AQ38757870-A3179C9A-6999-4544-A067-230034577B37Q38844790-37C535B6-9498-445F-9E74-82E91B05823BQ43898106-0B7F0AEE-6D8D-4DEC-8A16-77211FB96C39Q47619599-D4F6CCCD-42CD-4D53-B0AE-89A40F063C38Q48512500-24229D19-5855-4606-A194-229C5A7C591C
P2860
A review of the safety and tolerability of aripiprazole.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of the safety and tolerability of aripiprazole.
@en
A review of the safety and tolerability of aripiprazole.
@nl
type
label
A review of the safety and tolerability of aripiprazole.
@en
A review of the safety and tolerability of aripiprazole.
@nl
prefLabel
A review of the safety and tolerability of aripiprazole.
@en
A review of the safety and tolerability of aripiprazole.
@nl
P2860
P1476
A review of the safety and tolerability of aripiprazole.
@en
P2093
Chi-Un Pae
P2860
P304
P356
10.1517/14740330902835493
P407
P577
2009-05-01T00:00:00Z